Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06421597
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-20
First Post:
2024-05-03
Brief Title:
Identifying Individuals At Risk of Glucocorticoid-Induced Impairment of Bone Disease
Sponsor:
Odense University Hospital
Organization:
Odense University Hospital
Study Overview
Official Title:
Identifying Individuals At Risk of Glucocorticoid-Induced Impairment of Bone Disease
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RIGID
Brief Summary:
Previous studies have shown that there is a large inter-individual variability in the degree of bone loss during glucocorticoid treatment and while some patients experience extensive bone loss other patients39 bone mass remains stable The aim of the study is to find a biomarker that can be used to identify individuals at risk of glucocorticoid-induced bone loss The study will include 36 healthy volunteers that will be randomized to receive either glucocorticoid treatment or placebo During the study blood samples bone marrow samples bone tissue samples and adipose tissue samples are taken and an oral glucose tolerance test is performed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None